Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Inglib M 5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Ampho Healthcare

Salt Composition

Glibenclamide (5mg) + Metformin (500mg)

Overview Inglib M 5mg/500mg Tablet

Diabexe Duo 5mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabexe Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Familiarize yourself with its symptoms – sweating, dizziness, headache, tremors – and know how to counter it. Consistent meals and readily available glucose sources (sugary foods or juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart conditions should inform their physician before starting treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended by your doctor.

Uses of Inglib M 5mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Inglib M 5mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Inglib M 5mg/500mg Tablets. Swallow the tablet whole; do not crush, chew, or break it. Administer this medication with food.

Common Side effects of Inglib M 5mg/500mg Tablet:

  • Nausea
  • Vomiting
  • Diarrhea
  • Flatulence

How to use Inglib M 5mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Swallow the Inglib M 5mg/500mg tablet whole; avoid chewing, crushing, or breaking it. It should be administered with a meal.

How Inglib M 5mg/500mg Tablet works:

Each Inglib M 5mg/500mg tablet combines the antidiabetic agents glibenclamide (5mg) and metformin (500mg).

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Inglib M 5mg/500mg Tablet is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Inglib M 5mg/500mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, data from human clinical trials are currently scarce.

Breast feedingBreast feedingCAUTION

The use of Inglib M 5mg/500mg tablets requires careful consideration while breastfeeding. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Inglib M 5mg/500mg Tablet on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Inglib M 5mg/500mg Tablets due to potential safety concerns. A physician's consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Inglib M 5mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, a low starting dose is typically recommended, while use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Inglib M 5mg/500mg Tablet :

Should you forget to take your Inglib M 5mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Inglib M 5mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Inglib M 5mg/500mg Tablet

Inglib M 5mg/500mg tablets contain glibenclamide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances glycemic control when combined with a healthy diet and regular physical activity. Glibenclamide stimulates pancreatic insulin secretion, reducing blood glucose, while metformin decreases hepatic glucose output and improves cellular insulin responsiveness. This formulation is unsuitable for type 1 diabetes management.
Diabetes type 2, the prevalent form of diabetes, arises from the body's insufficient insulin production or ineffective insulin utilization. This deficiency results in elevated blood glucose, posing significant health risks. Characteristic symptoms of hyperglycemia encompass frequent urination, excessive thirst, and heightened appetite. Untreated, diabetes can induce chronic complications such as nerve damage (neuropathy), kidney damage (nephropathy), retinopathy (eye damage), foot complications, and an increased cardiovascular disease risk.
Inglib M 5mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Indeed, Inglib M 5mg/500mg Tablet can induce hypoglycemia (low blood glucose). Manifestations of low blood sugar may encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The likelihood of hypoglycemia increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Indeed, prolonged Inglib M 5mg/500mg Tablet consumption can lead to vitamin B12 deficiency due to impaired intestinal vitamin B12 absorption. This deficiency, if left unaddressed, might result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Prophylactic annual supplemental vitamin B12 is recommended by some studies to mitigate these risks.
Patients with hypersensitivity to any Inglib M 5mg/500mg Tablet constituent or inactive ingredient should not use this medication. Its use is contraindicated in individuals with moderate to severe renal impairment and those experiencing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Inglib M 5mg/500mg Tablet is unsafe due to the risk of exacerbated hypoglycemia and heightened lactic acidosis probability.
Maintain this medication within its original, sealed container or packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Prevent accidental ingestion by children, pets, and others.
Inglib M 5mg/500mg Tablet
55
MRP 68
18% off